We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Gives Thumbs Up for Eight Drugs, Including Two Biosimilars
CHMP Gives Thumbs Up for Eight Drugs, Including Two Biosimilars
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended eight new drugs for approval at its April meeting, including copycat versions of Novo Nordisk’s NovoLog insulin and Novartis’ multiple sclerosis drug Gilenya.